Your browser doesn't support javascript.
loading
Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn's disease.
Martini, Gabriela Rios; Tikhonova, Ekaterina; Rosati, Elisa; DeCelie, Meghan Bialt; Sievers, Laura Katharina; Tran, Florian; Lessing, Matthias; Bergfeld, Arne; Hinz, Sophia; Nikolaus, Susanna; Kümpers, Julia; Matysiak, Anna; Hofmann, Philipp; Saggau, Carina; Schneiders, Stephan; Kamps, Ann-Kristin; Jacobs, Gunnar; Lieb, Wolfgang; Maul, Jochen; Siegmund, Britta; Seegers, Barbara; Hinrichsen, Holger; Oberg, Hans-Heinrich; Wesch, Daniela; Bereswill, Stefan; Heimesaat, Markus M; Rupp, Jan; Kniemeyer, Olaf; Brakhage, Axel A; Brunke, Sascha; Hube, Bernhard; Aden, Konrad; Franke, Andre; Iliev, Iliyan D; Scheffold, Alexander; Schreiber, Stefan; Bacher, Petra.
Afiliação
  • Martini GR; Institute of Immunology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Tikhonova E; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Rosati E; Institute of Immunology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • DeCelie MB; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Sievers LK; Institute of Immunology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Tran F; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Lessing M; The Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Bergfeld A; Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Hinz S; Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Nikolaus S; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Kümpers J; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Matysiak A; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Hofmann P; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Saggau C; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Schneiders S; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Kamps AK; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Jacobs G; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Lieb W; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Maul J; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Siegmund B; Department of Internal Medicine I, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Seegers B; Institute of Immunology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Hinrichsen H; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Oberg HH; Institute of Immunology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Wesch D; Institute of Immunology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Bereswill S; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Heimesaat MM; Institute of Immunology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Rupp J; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Kniemeyer O; Institute of Epidemiology, Christian-Albrechts-University of Kiel and popgen Biobank, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Brakhage AA; Institute of Epidemiology, Christian-Albrechts-University of Kiel and popgen Biobank, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Brunke S; Gastroenterologie am Bayerischen Platz, Berlin, Germany.
  • Hube B; Department of Gastroenterology, Rheumatology and Infectious Diseases, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Aden K; Department of Gastroenterology, Rheumatology and Infectious Diseases, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Franke A; Gastroenterology-Hepatology Center Kiel, Kiel, Germany.
  • Iliev ID; Gastroenterology-Hepatology Center Kiel, Kiel, Germany.
  • Scheffold A; Institute of Immunology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Schreiber S; Institute of Immunology, Christian-Albrechts-University of Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Bacher P; Institute of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Nat Med ; 29(10): 2602-2614, 2023 10.
Article em En | MEDLINE | ID: mdl-37749331
ABSTRACT
Aberrant CD4+ T cell reactivity against intestinal microorganisms is considered to drive mucosal inflammation in inflammatory bowel diseases. The disease-relevant microbial species and the corresponding microorganism-specific, pathogenic T cell phenotypes remain largely unknown. In the present study, we identified common gut commensal and food-derived yeasts, as direct activators of altered CD4+ T cell reactions in patients with Crohn's disease (CD). Yeast-responsive CD4+ T cells in CD display a cytotoxic T helper cell (TH1 cell) phenotype and show selective expansion of T cell clones that are highly cross-reactive to several commensal, as well as food-derived, fungal species. This indicates cross-reactive T cell selection by repeated encounter with conserved fungal antigens in the context of chronic intestinal disease. Our results highlighted a role of yeasts as drivers of aberrant CD4+ T cell reactivity in patients with CD and suggest that both gut-resident fungal commensals and daily dietary intake of yeasts might contribute to chronic activation of inflammatory CD4+ T cell responses in patients with CD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Doença de Crohn Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Doença de Crohn Limite: Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha